Fenwick represented Devoted Health, a next-generation health company focused on dramatically improving the health and well-being of older Americans, in its $1.15 billion Series D financing.
The round was led by Uprising, with new partner SoftBank Vision Fund 2 co-leading with the largest investment. They are joined by returning investors GIC, Andreessen Horowitz, Premji Invest, Maverick, Frist Cressey Ventures and NextView Ventures, and new investors ICONIQ Growth, General Catalyst, the Base10 Advancement Initiative and Emerson Collective.
Devoted Health will use the funds to expand nationwide. More information can be obtained from the company's announcement.
The Fenwick transaction team was led by corporate partners Matthew Rossiter and Thomas Kang, and included associates Shweta Kumar, David A. Rand and Elizabeth Gil.